-
Product Insights
NewRubella (German Measles) – Drugs In Development, 2024
Empower your strategies with our Rubella (German Measles) – Drugs In Development, 2024 report and make more profitable business decisions. Rubella, also known as German measles, is an acute, contagious viral infection. The rubella virus is transmitted by airborne droplets when infected people sneeze or cough. Symptoms include fever, headache, stuffy or runny nose, red and inflamed eyes, aching joints, and enlarged, tender lymph nodes at the base of the skull, the back of the neck, and behind the ears. The...
-
Product Insights
NewRubivirus Infections – Drugs In Development, 2024
Empower your strategies with our Rubivirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Rubi virus Infections causes rubella and is placed in the Rubi virus genus of togaviridae family. It is a single stranded RNA virus causing infections most predominantly in children and is also known as German measles. Mode of transmission is through droplets contacts and spreads to other organs. It can also transmit from mother to fetus through placenta. In most cases it...
-
Product Insights
NewMeasles – Drugs In Development, 2024
Empower your strategies with our Measles – Drugs In Development, 2024 report and make more profitable business decisions. Measles is a highly infectious viral disease. The virus lives in the mucus of the nose and throat of people with this infection. Physical contact, coughing, and sneezing can spread the infection. Symptoms of measles are high temperature, sore eyes (conjunctivitis), and a runny nose, which usually occur first; small white spots usually develop inside the mouth a day or so later, with...
-
Product Insights
Yellow Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Yellow Fever – Drugs In Development, 2022, provides an overview of the Yellow Fever (Infectious Disease) pipeline landscape. Yellow fever is an acute systemic illness (hemorrhagic fever) caused by the Flavivirus. It is spread by mosquitoes. Symptoms include irregular heartbeats, bleeding, vomiting, coma, delirium, fever, headache and muscle aches. There is no specific treatment for yellow fever but can be treated to relieve the symptoms. Report Highlights Global Markets Direct's...
-
Product Insights
Yellow Fever Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2018" provides an overview of Yellow Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Yellow Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Brazil In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.
GlobalData’s “Brazil In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Brazil In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The Brazil In Vitro Diagnostics Market report provides key information and data on: • Annualized market revenues (USD), volume...
-
Sector Analysis
Brazil Infectious Disease Market Outlook to 2025
GlobalData’s “Brazil Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Brazil Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic...